EGFR and head and neck squamous cell carcinoma: Moderate or strong K721 EGFR mono-methylation was detected in 82% of patients with HNSCC, which may potentiate its interaction with proliferating cell nuclear antigen (PCNA), stabilize PCNA, and promote DNA replication in HNSCC cells.